Rapid Dose Therapeutics Corp.
RDTCF
$0.18
$0.0320.00%
| Weiss Ratings | RDTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | RDTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Good | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | RDTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 24.13 | |||
| Price History | RDTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | -0.83% | |||
| 90-Day Total Return | -14.29% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | 114.29% | |||
| 2-Year Total Return | 44,900.00% | |||
| 3-Year Total Return | -10.00% | |||
| 5-Year Total Return | -21.74% | |||
| 52-Week High % Change | -53.85% | |||
| 52-Week Low % Change | 6,106.90% | |||
| Price | RDTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.39 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | May 17, 2024 | |||
| 52-Week High Price (Date) | Jul 03, 2024 | |||
| Valuation | RDTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 17.38M | |||
| Enterprise Value | 19.16M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.04 | |||
| Earnings Per Share Growth | 41.41% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 19.15 | |||
| Price/Book (Q) | -7.89 | |||
| Enterprise Value/Revenue (TTM) | 15.12 | |||
| Price | $0.18 | |||
| Enterprise Value/EBITDA (TTM) | -6.48 | |||
| Enterprise Value/EBIT | -6.04 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | RDTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 124.17M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | RDTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 416 477 1052 | |||
| Address | 1121 Walker's Line Burlington, ON L7N 2G4 | |||
| Website | rapid-dose.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | RDTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -250.08% | |||
| Profit Margin | -360.57% | |||
| Management Effectiveness | RDTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -138.33% | |||
| Return on Equity | -- | |||
| Income Statement | RDTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.18M | |||
| Total Revenue (TTM) | 1.18M | |||
| Revenue Per Share | $0.01 | |||
| Gross Profit (TTM) | 702.40K | |||
| EBITDA (TTM) | -2.75M | |||
| EBIT (TTM) | -2.95M | |||
| Net Income (TTM) | -4.25M | |||
| Net Income Avl. to Common (TTM) | -4.25M | |||
| Total Revenue Growth (Q YOY) | 112.90% | |||
| Earnings Growth (Q YOY) | -38.03% | |||
| EPS Diluted (TTM) | -0.04 | |||
| EPS Diluted Growth (Q YOY) | -14.29% | |||
| Balance Sheet | RDTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 28.60K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 456.40K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -2.93M | |||
| Current Ratio (Q) | 0.202 | |||
| Book Value Per Share (Q) | -$0.02 | |||
| Total Assets (Q) | 1.19M | |||
| Total Current Liabilities (Q) | 2.26M | |||
| Total Debt (Q) | 1.86M | |||
| Total Liabilities (Q) | 4.12M | |||
| Total Common Equity (Q) | -2.93M | |||
| Cash Flow | RDTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 1.71M | |||
| Net Change in Cash (TTM) | -92.20K | |||
| Levered Free Cash Flow (TTM) | -1.63M | |||
| Cash from Operations (TTM) | -1.80M | |||
